Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost

Source: news.google.com

Published: May 21, 2026 07:00

Read Original Source

Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost Health Policy Watch

Detailed source content is still being fetched from the original article. Use the source link above for the live story.

Courtesy Link

https://news.google.com/rss/articles/CBMifEFVX3lxTE9aY3dxVFJ1eC1lM082TDR5MkpwV3B5TmE4Vl9sOXNLckwzOTd5eXJEczg1M2hZc2s1Z3drRnRUOE5jenl5dGk5VGoxSDM3a1EwcE94T18tRGthX1RVMXVndUszSVJycGJnOTlDWTc5a2J5UlRuSFA2bWQ5djQ?oc=5

More from this topic and section

The Clinical Trial Vanguard · 5 hours ago Biotech

Phathom Completes Enrollment in Phase 2 Vonoprazan EoE Trial Ahead of Schedule

Phathom Completes Enrollment in Phase 2 Vonoprazan EoE Trial Ahead of Schedule The Clinical Trial Vanguard

#Clinical Trials

The Clinical Trial Vanguard · 5 hours ago Biotech

When Your CRO’s AI Platform Upgrades, Who Pays for the Change Management?

When Your CRO’s AI Platform Upgrades, Who Pays for the Change Management? The Clinical Trial Vanguard

#Clinical Trials

facebook.com · 6 hours ago Biotech

St. Luke’s becomes the first private hospital in the Philippines to house this photon-counting CT scanner, reinforcing its leadership in medical innovation. Know more here: #PartneredUp

St. Luke’s becomes the first private hospital in the Philippines to house this photon-counting CT scanner, reinforcing its leadership in medical innovation. Know more here: #PartneredUp facebook.com

#Health Innovation

intlbm · 7 hours ago Biotech

Abu Dhabi Partners with MSD to Boost Healthcare Innovation

Abu Dhabi Partners with MSD to Boost Healthcare Innovation intlbm

#Health Innovation

Financial Times · 8 hours ago Biotech

Patent cliffs aren’t the only driver of the biotech M&A boom

Patent cliffs aren’t the only driver of the biotech M&A boom Financial Times

#Biotech Headlines

Yahoo Finance · 12 hours ago Biotech

VERAXA Biotech (VRXA) Expands Heidelberg R&D Facilities To Support Drug Development Pipeline

VERAXA Biotech (VRXA) Expands Heidelberg R&D Facilities To Support Drug Development Pipeline Yahoo Finance